Skip to main content

Altamira Therapeutics Ltd (NQ: CYTO )

1.120 UNCHANGED
Streaming Delayed Price Updated: 3:51 PM EDT, Jun 21, 2024 Add to My Watchlist

Other Filings

Form 424B2
Source: SEC/Edgar
October 23, 2002
Form S-3/A
Source: SEC/Edgar
October 20, 2002
Form DEF 14A
Source: SEC/Edgar
October 06, 2002
Form S-3
Source: SEC/Edgar
October 03, 2002
Form DEFA14A
Source: SEC/Edgar
September 25, 2002
Form DEFA14A
Source: SEC/Edgar
September 25, 2002
Form PRE 14A
Source: SEC/Edgar
September 25, 2002
Form 8-K
Source: SEC/Edgar
September 16, 2002
Form 8-K
Source: SEC/Edgar
August 18, 2002
Form SC 13G/A
Source: SEC/Edgar
July 08, 2002
Form 11-K
Source: SEC/Edgar
June 26, 2002
Form SC 13G/A
Source: SEC/Edgar
June 05, 2002
Form 424B2
Source: SEC/Edgar
June 03, 2002
Form 8-K
Source: SEC/Edgar
June 03, 2002
Form 8-K
Source: SEC/Edgar
May 30, 2002
Form 8-K
Source: SEC/Edgar
May 23, 2002
Form ARS
Source: SEC/Edgar
May 23, 2002
Form 8-K/A
Source: SEC/Edgar
May 21, 2002
Form 8-K
Source: SEC/Edgar
May 19, 2002
Form DEF 14A
Source: SEC/Edgar
April 24, 2002
Form PRE 14A
Source: SEC/Edgar
April 14, 2002
Form SC 13G/A
Source: SEC/Edgar
February 11, 2002
Form 8-K
Source: SEC/Edgar
January 23, 2002
Form 424B2
Source: SEC/Edgar
January 21, 2002
Form S-8
Source: SEC/Edgar
December 16, 2001
Form S-3
Source: SEC/Edgar
October 24, 2001
Form 11-K
Source: SEC/Edgar
July 25, 2001
Form 424B2
Source: SEC/Edgar
June 18, 2001
Form 8-K
Source: SEC/Edgar
June 18, 2001
Form DEF 14A
Source: SEC/Edgar
April 29, 2001
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.